Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

Share Price is delayed by 15 minutes
Get Live Data
130.00    -0.90 (-0.69%)
Bid:
129.50
Ask:
129.90
Spread: 0.40 (0.309%)
Market Cap: £328.76m
MSLH Live PriceLast checked at - London Stock Exchange

Intraday Marshalls Share Chart

Director/PDMR Shareholding

3 Oct 2008 15:29

RNS Number : 0817F
Marshalls PLC
03 October 2008
 



Directors' and PDMR interests in shares

Marshalls plc ("the Company") announces that it received notification on October 2008 that the Trustee of the Company's HM Revenue & Customs approved share purchase plan ("the Plan"), Yorkshire Building Society, purchased ordinary shares of 25 pence each on behalf of the following Directors and Persons Discharging Managerial Responsibility on October 2008, to be held in accordance with the rules of the Plan. The shares were purchased at a price of 158 pence per share.

Director

No. of Shares purchased

David Graham Holden

79

Ian David Burrell

79

David Neil Sarti

79

Christopher Harrop

79

Marshalls plc also received notification on 3 October 2008 of the transfer by Mr David Sarti, Executive Director, by means of a matched sale and purchase, of 2,280 ordinary shares beneficially held by him into a PEP. The shares were sold at a price of 155 pence per share and re-purchased through the PEP at a price of 156 pence per share on 2 October 2008. The total beneficial holding of Mr David Sarti is now 108,069 ordinary shares (including shares purchased through the Plan) representing 0.077% of the issued share capital of the Company.

Enquiries:

Cathy BaxandallCompany Secretary, Marshalls plc, tel: 01484 438900

3 October 2008

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEALEDEAAPFFE
Date   Source Headline
14th Jul 202211:51 amRNSDirector/PDMR Shareholding
12th Jul 20227:00 amRNSTrading Statement
11th May 20221:34 pmRNSResult of AGM
11th May 20227:00 amRNSTrading Statement
10th May 20223:14 pmRNSDirector/PDMR Shareholding
10th May 20223:02 pmRNSDirector/PDMR Shareholding
5th May 20229:19 amRNSHolding(s) in Company
3rd May 20224:20 pmRNSHolding(s) in Company
3rd May 20223:09 pmRNSDirector/PDMR Shareholding
3rd May 20223:08 pmRNSDirector/PDMR Shareholding
3rd May 20223:07 pmRNSDirector/PDMR Shareholding
3rd May 20223:06 pmRNSDirector/PDMR Shareholding
3rd May 20223:03 pmRNSDirector/PDMR Shareholding
3rd May 20223:02 pmRNSDirector/PDMR Shareholding
3rd May 20223:01 pmRNSDirector/PDMR Shareholding
3rd May 20223:00 pmRNSDirector/PDMR Shareholding
3rd May 20222:57 pmRNSDirector/PDMR Shareholding
3rd May 20222:53 pmRNSDirector/PDMR Shareholding
3rd May 20229:54 amRNSHolding(s) in Company
29th Apr 20228:25 amRNSTotal Voting Rights
29th Apr 20228:05 amRNSAcquisition
28th Apr 202211:51 amRNSAcquisition
27th Apr 202210:01 amRNSDirector Declaration
7th Apr 20221:50 pmRNSPublication of Prospectus
7th Apr 20227:00 amRNSResults of Accelerated Bookbuild
6th Apr 20224:46 pmRNSProposed Acquisition of Marley Group & Fundraising
5th Apr 20228:58 amRNSAnnual Financial Report
4th Apr 20228:54 amRNSHolding(s) in Company
18th Mar 20223:44 pmRNSDirector/PDMR Shareholding
18th Mar 20223:43 pmRNSDirector/PDMR Shareholding
17th Mar 20227:15 amRNSBoard Appointment
17th Mar 20227:00 amRNSFinal Results
4th Mar 20229:48 amRNSDirector/PDMR Shareholding
4th Feb 20222:42 pmRNSDirector/PDMR Shareholding
31st Jan 202210:29 amRNSDirector Declaration
18th Jan 20227:00 amRNSTrading Statement
5th Jan 20222:31 pmRNSDirector/PDMR Shareholding
14th Dec 202111:26 amRNSDirectorate Change
6th Dec 202110:51 amRNSDirector/PDMR Shareholding
11th Nov 20212:58 pmRNSDirector/PDMR Shareholding
5th Oct 202110:32 amRNSDirector/PDMR Shareholding
1st Oct 20214:03 pmRNSDirector/PDMR Shareholding
29th Sep 20214:09 pmRNSDirector/PDMR Shareholding
21st Sep 20213:54 pmRNSDirector/PDMR Shareholding
21st Sep 20213:53 pmRNSDirector/PDMR Shareholding
7th Sep 20212:06 pmRNSDirector/PDMR Shareholding
20th Aug 20214:57 pmRNSHolding(s) in Company
19th Aug 20217:00 amRNSHalf-year Report
4th Aug 202111:57 amRNSDirector Declaration
19th Jul 20216:15 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.